Importantly, both variants showed opposite effects on cell viability, which significantly differ from wt SMAD5 and, therefore, can be considered variants altering cell characteristics involved in the underlying molecular processes of PAH. Here, SMAD5 is linked to pulmonary arterial hypertension.